PGL 0.00% 85.0¢ prospa group limited.

bioalliance pharma suspends phase ii iii trial, page-3

  1. 1,098 Posts.
    I see them as competing with PGL in this space of primary liver cancer, so if they can't make it to the next level I guess it is good news for PGL.
 
watchlist Created with Sketch. Add PGL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.